Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.01, read 2026-10-27
Ethical does not pass the values gate
Price7.45 USD
Fair value14.00
Ethical score30.0/100
Our investment reviews on this name
2026-10-23Read Markdown7.90-5.7% to today ✓Accumulation gives way to Markdown after a 25% rise in 10 weeks
2026-08-12Read Accumulation6.32+17.9% to today ✓Markdown gives way to Accumulation after a 15% rise in 6 weeks
2026-07-02Read Markdown5.51+35.2% to today First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Sharplink, Inc. holds its Markdown at $7.45. The statistical read favours the sellers, held for 265 days.
As held on the ledger · 2026-10-27
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 265 days
Price at the screen
$7.45
Valuation
N/A trailing · -124.17 forward price to earnings
Values screen
FAIL· score 30.0
Beta
10.59
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: financial services
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Sharplink, does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SBET's ethical verdict changes
Today SBET does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 87.9% margin of safety to the base estimate.
Third-party analyst targets: 8 covering, consensus Strong Buy. The average target sits +88% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Ethereum treasury play fails ethical screen test
Sharplink runs an Ethereum treasury platform that promises to manage digital assets for institutions while mixing in affiliate marketing on the side. The numbers look wild on paper with revenue exploding over fifteen times and a forward multiple below three times earnings yet nothing reaches the bottom line and return on equity sits deep in negative territory.
We pass for one clear reason that overrides every other data point. The business sits inside financial services and our screen blocks the entire sector without exception. This is exactly what the screen is for.
High growth from a tiny base often hides execution risk and zero profits leave no margin for error when crypto markets turn. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SBET trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-23Markdown · changed$7.90+0.0%Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 85%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (8 analysts) rates it none, with a mean price target of $18. Insiders have been net sellers over the past quarter.
2026-10-16Accumulation$7.90-20.6%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 20.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 85%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (8 analysts) rates it none, with a mean price target of $18. Insiders have been net sellers over the past quarter.
2026-10-02Accumulation$9.95+14.6%Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 85%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (8 analysts) rates it none, with a mean price target of $18.
2026-09-12Accumulation$8.68+37.3%Entry 5
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 37.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 85%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (8 analysts) rates it none, with a mean price target of $18.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 85%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (8 analysts) rates it none, with a mean price target of $18.
2026-07-18Markdown$5.51+0.0%Entry 3
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 85%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (8 analysts) rates it none, with a mean price target of $18.
2026-07-03Markdown$5.51+0.0%Entry 2
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markdown$5.51Entry 1
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
